Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EMBO, EMBC and the National Science Council of Taiwan Sign Cooperation Agreement

Published: Thursday, November 29, 2012
Last Updated: Thursday, November 29, 2012
Bookmark and Share
New ways of global scientific interaction have been created following a cooperation agreement between EMBO, the European Molecular Biology Conference (EMBC), and the National Science Council of Taiwan (NSC).

The agreement will allow Taiwanese scientists to participate in EMBO training programmes and activities. It also means that EMBO Courses & Workshops can take place at Taiwanese research institutes.

This is the first cooperation agreement of its kind between EMBO, EMBC and Taiwanese scientists, represented by NSC and Academia Sinica. The Taipei City-based Academia Sinica and NSC work together to create new opportunities for Taiwanese life scientists.


“EMBO promotes and encourages the development of the life sciences within Europe and beyond. We encourage the global mobility of scientists and we look forward to the increased scientific collaboration that this agreement will bring,” said EMBO Director Maria Leptin.

EMBO Associate Member and Academia Sinica President Chi-Huey Wong said: “EMBO is a leading organization that fosters new generations of life science researchers producing world-class scientific results. It is our delight to create great opportunities for young Taiwanese scientists to connect with the elite scientists of Europe.”

Representing the NSC, the cooperation agreement was signed by Minister Cyrus C.Y. Chu. He said: “This agreement opens up a gateway for Taiwanese life scientists to interact with some of the world’s brightest minds. We anticipate that more Taiwanese scientists will form affiliations with leading European life scientists because of this agreement.”

Under the terms of the agreement, scientists can apply for EMBO Short-Term and Long-Term Fellowships. Young Taiwanese group leaders will be eligible to benefit from the EMBO Young Investigator Programme, which provides outstanding young scientists with financial, academic and practical support to start up their first independent research laboratories.

Taiwanese scientists and EMBO will also cooperate in the organization of EMBO Courses & Workshops, which will help to spark collaborations between different scientific disciplines. Earlier this year, Academia Sinica and EMBO jointly organized the lecture course “Logic of Regulatory Circuits in Life Sciences” in Taipei City.

Conference organizers can apply for funding for plenary lectures given by EMBO Members or lectures given by EMBO Young Investigators at Taiwanese institutes and universities. Travel stipends will be available for Taiwanese scientists to attend EMBO Courses & Workshops and The EMBO Meeting.

The cooperation agreement will run for three years.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Systems-Wide Genetic Investigation Of Blood Pressure Regulation
A genetic investigation of individuals in the Framingham Heart Study may prove useful to identify novel targets for the prevention or treatment of high blood pressure.
Friday, April 17, 2015
Small Non-coding RNAs Could be Warning Signs of Cancer
Results are published in EMBO reports.
Tuesday, February 18, 2014
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!